(Q44616169)

English

A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles

scientific article published on November 10, 2003

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A randomised comparison of side effects and patient inconvenience of two vaginal progesterone formulations used for luteal support in in vitro fertilisation cycles (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

1

object named as

Ernest H. Y. Ng

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14557011

21 March 2024

author name string

Benyu Miao

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Wai Cheung

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Pak-Chung Ho

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14557011

21 March 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

10 November 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14557011

21 March 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0301211503001568?httpAccept=text/xml

1 reference

10.1016/S0301-2115(03)00156-8

https://api.crossref.org/works/10.1016/S0301-2115(03)00156-8

21 March 2024

https://api.elsevier.com/content/article/PII:S0301211503001568?httpAccept=text/plain

1 reference

10.1016/S0301-2115(03)00156-8

https://api.crossref.org/works/10.1016/S0301-2115(03)00156-8

21 March 2024

European Journal of Obstetrics Gynecology and Reproductive Biology

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

111

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

50-54

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Luteal phase support in infertility treatment: a meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro fertilization and the ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The choice of luteal support following pituitary down regulation, controlled ovarian hyperstimulation and in vitro fertilisation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison between different routes of progesterone administration as luteal phase support in infertility treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted drug delivery in gynaecology: the first uterine pass effect

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral progesterone (P) levels and endometrial response to various dosages of vaginally administered P in estrogen-primed women

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative bioavailability of orally and vaginally administered progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of vaginal administration of progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0301-2115(03)00156-8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44616169&oldid=2107411630"